2,679
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Biological investigations on therapeutic effect of chitosan encapsulated nano resveratrol against gestational diabetes mellitus rats induced by streptozotocin

, , , , , , & show all
Pages 953-963 | Received 15 Mar 2020, Accepted 25 May 2020, Published online: 02 Jul 2020

References

  • Ables GP, Perrone CE, Orentreich D, Orentreich N. (2012). Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density. PLoS One 7:e51357.
  • Ademiluyi AO, Oboh G. (2013). Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro. Exp Toxicol Pathol 65:305–9.
  • Al-Hussaini H, Kilarkaje N. (2018). Effects of trans-resveratrol on type 1 diabetes-induced inhibition of retinoic acid metabolism pathway in retinal pigment epithelium of Dark Agouti rats. Eur J Pharmacol 834:142–51.
  • Ali H, Houghton PJ, Soumyanath A. (2006). alpha-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol 107:449–55.
  • Baur JA, Pearson KJ, Price NL, et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature (London, UK) 444:337–42.
  • Baur JA. (2010). Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 131:261–9.
  • Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. (1997). Novel hydrophilic chitosan polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63:125–32.
  • Chauhan P, Mahajan S, Prasad GBKS. (2019). Preparation and characterization of CS-ZnO-NC nanoparticles for imparting anti-diabetic activities in experimental diabetes. J Drug Deliv Sci Technol 52:738–47.
  • Cheng JG, Tian BR, Huang Q, et al. (2018). Resveratrol functionalized carboxymethyl-β-cyclodextrin: synthesis, characterization, and photostability. J Chem 2018:1–7.
  • Dhanavel S, Nivethaa EAK, Narayanan V, Stephen A. (2014). Photocatalytic activity of chitosan/ZnO nanocomposites for degrading methylene blue. Int J ChemTech Res 6:1880–2.
  • Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, et al. (2010). A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 46:212–23.
  • Gardosi J, Francis A. (2009). A customized standard to assess fetal growth in a US population. Am J Obstet Gynecol 201:25 e21–27.
  • Georgoulis M, Kontogianni MD, Yiannakouri N. (2014). Mediterranean diet and diabetes: prevention and treatment. Nutrients 6:1406–23.
  • Gocmez SS, Şahin TD, Yazir Y, et al. (2019). Resveratrol prevents cognitive deficits by attenuating oxidative damage and inflammation in rat model of streptozotocin diabetes induced vascular dementia. Physiol Behav 201:198–207.
  • Greca M, Zarrelli A. (2012). Nutraceuticals and Mediterranean diet. Med Aromat Plants 1:e126.
  • IDF. (2015). Diabetes Atlas. 7th ed. Available at: http://www.diabetesatlas.org/resources/2015-atlas.html [last accessed 25 Apr 2017].
  • Jeong H, Samdani KJ, Yoo DH, et al. (2016). Resveratrol cross-linked chitosan loaded with phospholipid for controlled release and antioxidant activity. Int J Biol Macromol 93:757–66.
  • Kim J, Lee S. (2012). Effect of zinc supplementation on insulin resistance and metabolic risk factors in obese Korean women. Nutr Res Pract 6:221–5.
  • Klein K, Satler M, Elhenicky M, et al. (2008). Circulating levels of MCP-1 are increased in women with gestational diabetes. Prenat Diagn 28:845–51.
  • Lee AS. (2005). The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 35:373–81.
  • Loizzo MR, Saab AM, Tundis R, et al. (2008). In vitro inhibitory activities of plants used in Lebanon traditional medicine against angiotensin converting enzyme (ACE) and digestive enzymes related to diabetes. J Ethnopharmacol 119:109–16.
  • Maret W. (2017). Zinc in pancreatic islet biology, insulin sensitivity, and diabetes. Prev Nutr Food Sci 22:1–8.
  • Matthews DR, Hosker JP, Rudenski AS, et al. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–9.
  • McKeown NM, Meigs JB, Liu S, et al. (2004). Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care 27:538–46.
  • Mukherjee B, Mukherjee JR, Chatterjee M. (1994). Lipid peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetic rats. Immunol Cell Biol 72:109–14.
  • Nimse SB, Pal D. (2015). Free radicals, natural antioxidants, and their reaction mechanisms. RSC Adv 5:27986–8006.
  • Olholm J, Paulsen SK, Cullberg KB, et al. (2010). Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int J Obes 34:1546–53.
  • Pearson KJ, Baur JA, Lewis KN, et al. (2008). Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8:157–68.
  • Prasad SA. (2013). Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr 4:176–90.
  • Rahal A, Kumar A, Singh V, et al. (2014). Oxidative stress, prooxidants, and antioxidants: the interplay. BioMed Res Int 2014:1–19.
  • Ristagno G, Fumagalli F, Porretta-Serapiglia C, et al. (2012). Hydroxytyrosol attenuates peripheral neuropathy in streptozotocin-induced diabetes in rats. J Agric Food Chem 60:5859–65.
  • Roemer K, Mahyar-Roemer M. (2002). The basis for the chemopreventive action of resveratrol. Drugs Today 38:571–80.
  • Searle AJ, Willson RL. (1980). Glutathione peroxidase: effect of superoxide, hydroxyl and bromine free radicals on enzyme activity. Int J Radiat Biol Relat Stud Phys Chem Med 37:213–7.
  • Sha H, Zeng H, Zhao J, Jin H. (2019). Mangiferin ameliorates gestational diabetes mellitus-induced placental oxidative stress, inflammation and endoplasmic reticulum stress and improves fetal outcomes in mice. Eur J Pharmacol 859:172522.
  • Shai LJ, Masoko P, Mokgotho MP, et al. (2010). Yeast alpha glucosidase inhibitory and antioxidant activities of six medicinal plants collected in Phalaborwa. S Afr J Bot 76:465–70.
  • Simioni C, Zauli G, Martelli AM, et al. (2018). Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging. Oncotarget 9:17181–98.
  • Singh B, Saxena A. (2010). Surrogate markers of insulin resistance: a review. World J Diabetes 1:36–47.
  • Timmers S, Konings E, Bilet L, et al. (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14:612–22.
  • Vasto S, Barera A, Rizzo C, et al. (2014). Mediterranean diet and longevity: an example of nutraceuticals? Curr Vasc Pharmacol 12:735–8.
  • Wojcik M, Zieleniak A, Zurawska-Klis M, et al. (2016). Increased expression of immune-related genes in leukocytes of patients with diagnosed gestational diabetes mellitus (GDM). Exp Biol Med (Maywood) 241:457–65.
  • Xu K, Liu S, Zhao X, et al. (2019). Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol. Biomed Pharmacother 110:844–9.